Is Elevance Health (ELV) Entering a Major Earnings Recovery?
Covered in this story
What has happened since
- Elevance Health is up 16.4% since this was published, 77 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Elevance Health
- Guggenheim: $421 → $460 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $ELV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Elevance Health →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.